Abstract
BackgroundMyelodysplastic syndromes (MDS) are a heterogeneous group of clonal haematopoietic neoplasms, characterised by the presence of morphological and functional alterations in different haematopoietic cell lines and anaemia, leucopenia and thrombocytopenia....
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have